Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma

Experimental Oncology

Volumn 28, Issue 1, 2006, Pages 54-60

  Gamaleia, N F ^a   Skivka, L M ^b   Fedorchuk, A G ^a   Shishko, E D ^a  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

Author keywords

Circadian rhythm; Malignant melanoma; NK cell activity; Phagocytes cytotoxic activity

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER STAGING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MELANOMA; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; RADIOIMMUNOASSAY;

CIRCADIAN RHYTHM; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MELANOMA; PHAGOCYTES; REFERENCE VALUES;

EID: 33646062566     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Canaple L, Kakizawa T, Laudet V. The days and nights of cancer cells. Cancer Res 2003; 63: 7545-52.
2. Van Gelder RN. Recent insights into mammalian circadian rhythms. Sleep 2004; 2: 166-71.
3. Boivin DB, James FO, Wu A, Cho-Park PF, Xiong H, Sun ZS. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 2003; 102: 4143-5.
4. Arjona A, Boyadjieva N, Sarkar DK. Circadian rhythms of granzyme B, perform, IFN-gamma, and NK cell cytolytic activity in the spleen: effects of chronic ethanol. J Immunol. 2004; 172: 2811-7.
5. Bovbjerg DH. Circadian disruption and cancer: sleep and immune regulation. Brain Behav Immun 2003; 17: 48-53.
6. Fu L, Lee CC. The Circadian clock: pacemaker and tumor suppressor. Nat Rev Cancer 2003; 3: 350-8.
7. Spiegel D, Sephton SE. Psychoneuroimmune and endocrine pathways in cancer: effects of stress and support. Semin Clin Neuropsychiatry. 2001; 6: 252-65.
8. Filipski E, King VM, Li X, Granda TG, Mormont MC, Claustrat B, Hastings MH, Levi F. Disruption of Circadian coordination accelerates malignant growth in mice. Pathol Biol 2003; 51: 216-9.
9. Mormont MC, Langouet AM, Claustrat B, Bogdan A, Marion S, Waterhouse J, Touitou Y, Levi F. Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int 2002; 19: 141-55.
10. Touitou Y, Levi F, Bogdan A, Benavides M, Bailleul F, Misset JL. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol 1995; 121: 181-8.
11. Filipski K, King VM, Granda TG, Mormout MC, Liu X, Claustrat B, Hastings MH, Levi F. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002; 94: 690-7.
12. Mussi C, Angelini C, Crippa S, Caprotti R, Fumagalli L, Motta V, Uggeri F. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients. Hepatogastroenterology 2003; 50: ccxxviii-ccxxxi.
13. Crippa S, Mussi C, Angelini C, Caprotti R, Bonardi C, Muselli P, Scotti M, Piacentini G, Uggeri F. Alteration of hypothalamus-pituitary-adrenal gland axis in colorectal cancer patients. Prelim Report Minerva Chir 2003; 58: 581-5
14. Mormon MC, Bogdan A, Cormont S, Touitou Y, Levi F. Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome. Anticancer Res 2002; 22: 1243-9.
15. Mazzoccoli G, Correra M, Bianco G, De Cata A, Balzanelli M, Giuliani A, Tarquini R. Age-related changes of neuro-endocrine-immune interactions in healthy humans. J Biol Regul Homeost Agents 1997; 11: 143-7.
16. Kronfol Z, Nair M, Zhang Q, Hill EE, Brown MB. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom Med 1997; 59: 42-50.
17. Esquifino AI, Arce A, Alvarez MP, Chacon F, Brown-Borg H, Bartke A. Differential effects of light/dark recombinant human prolactin administration on the submaxillary lymph nodes and spleen activity of adult male mice. Neuroimmunomodulation 2004; 11: 119-26.
18. Mazzoccoli G, Balzanelli M, Giuliani A, De Cata A, La Viola M, Carella AM, Bianco G, Tarquini R. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease. In Vivo 1999; 13: 205-9.
19. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993; 246: 89-96.
20. Fraschini F, Demartini G, Esposti D, Scaglione F. Melatonin involvement in immunity and cancer. Biol Signal Recept 1998; 7: 61-72.
21. Zaretskaya JM. Clinicheskaya immunogenetica. M: Medgiz, 1983: 159-160 (in Russian).
22. Nielsen LR, Kimose HH, Linnet L, Moller NP, Bukh A. Analysis of the decreased NK-activity in lung cancer patients using whole blood. J Clin Lab Immunol 1989; 29: 71-7.
23. Gratcheva MP. Determination of bactericide activity of alweolar macrophages in a NBT-test. J Microbiol Epidemiol Immunol 1984; 2: 87-8 (in Russian).
24. Muller F, Rollag A, Froland SS. Nitroblue tetrasolium reduction in monocytes and monocyte derived macrophages. APMIS 1989; 97: 490-6.
25. Haus E, Lakatua DJ, Soyer J, Sacket-Lundeen L. Chronobiology in hematology and immunology. Am J Anat 1983; 168: 467-517.
26. Gubler EV. Computing methods of analysis and recognition in pathologic processes. Leningrad: Medicina 1988, 307 p (in Russian).
27. Gamaleya NF, Shishko ED, Chorny AG. Human lymphocyte circadian rhythm preservation in vitro. BEMB 1988; CVI: 598-600 (in Russian).
28. Gamaleya NF, Shishko ED, Gorobets OB. Cell model for study of effect of gravitation changing on circadian rhythm in human. Kosm Nauka Technol 2004; 10: 204-7 (in Russian).
29. Gamaleya NF, Skivka LM, Fedorchuk AG, Kondrichin IG. Seasonal changing of circadian rhythm of human leucocytes cytotoxic activity. Immunologia. Dep in State Med library ND-25524 14.04.97 (in Russian)
30. Akbulut H, Icli F, Buyukcelik A, Buyukcelik A, Aklut KG, Demirci S. The role of granulocyte-macrophage-colony stimulating factor, cortisol and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer. J Pineal Res 1999; 26: 1-8.
31. Raida M, Kliche KO, Schwabe W, Haulser P, Clement JH, Behnke D, Hoffken K. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leucocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls. J Cancer Res Clin Oncol 2002; 128: 96-102.
32. Fraschini F, Demartini G, Esposti D, Scadlione F. Melatonin involvement in immunity and cancer. Biol Signal Recept 1998; 7: 61-72.
33. Vician M, Zeman M, Herichova I, Jurani M, Blazicek P, Matis P. Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery. J Pineal Res 1999; 27: 164-9.
34. Pang SF, Pang CS, Poon AM, Lee PP, Liu ZM, Shiu SY. Melatonin: a chemical photoperiodic signal with clinical significance in human. Clin Med J (Engl) 1998; 111: 197-203.
35. Wetterberg L. Melatonin and clinical application. Report Nutr Dev 1999; 39: 367-82.